Ignite Creation Date:
2025-12-25 @ 2:06 AM
Ignite Modification Date:
2025-12-26 @ 4:47 AM
Study NCT ID:
NCT04313660
Status:
UNKNOWN
Last Update Posted:
2020-03-18
First Post:
2020-03-13
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Anlotinib In Combination With PD-1/L1 Inhibitor As Sequential Therapy of Thoracic Radiotherapy After Induction Chemotherapy For Extensive-Stage Small Cell Lung Cancer:A Single Arm Study
Sponsor:
Xiaorong Dong
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2020-04
Start Date Type:
ESTIMATED
Primary Completion Date:
2021-02
Primary Completion Date Type:
ESTIMATED
Completion Date:
2022-02
Completion Date Type:
ESTIMATED
First Submit Date:
2020-03-13
First Submit QC Date:
None
Study First Post Date:
2020-03-18
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2020-03-16
Last Update Post Date:
2020-03-18
Last Update Post Date Type:
ACTUAL